Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EYENASDAQ:NVAXNASDAQ:RXSTNYSE:WRBY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEYENational Vision$18.86+0.5%$12.56$9.56▼$18.93$1.49B1.021.76 million shs2.85 million shsNVAXNovavax$6.19-2.4%$6.83$5.01▼$23.86$995.62M3.217.47 million shs5.62 million shsRXSTRxSight$13.20-4.0%$18.77$13.03▼$64.50$536.41M1.32664,499 shs953,513 shsWRBYWarby Parker$18.49-2.1%$17.15$12.46▼$28.68$1.93B2.011.81 million shs3.13 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEYENational Vision+0.53%+41.22%+63.43%+58.89%+26.24%NVAXNovavax-2.37%+1.98%+5.63%-20.95%-52.78%RXSTRxSight-4.00%-5.38%-6.25%-58.62%-77.55%WRBYWarby Parker-2.09%+13.68%+24.72%-29.35%+19.37%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEYENational Vision2.625 of 5 stars2.32.00.03.34.00.00.0NVAXNovavax3.6717 of 5 stars3.21.00.04.73.10.80.6RXSTRxSight2.7967 of 5 stars4.11.00.00.02.82.50.6WRBYWarby Parker2.996 of 5 stars3.33.00.00.02.04.20.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEYENational Vision 2.50Moderate Buy$17.57-6.83% DownsideNVAXNovavax 2.43Hold$19.00206.95% UpsideRXSTRxSight 2.20Hold$37.60184.85% UpsideWRBYWarby Parker 2.69Moderate Buy$22.0018.98% UpsideCurrent Analyst Ratings BreakdownLatest RXST, WRBY, EYE, and NVAX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/13/2025WRBYWarby ParkerUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$23.00 ➝ $20.005/12/2025EYENational VisionBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$14.00 ➝ $17.005/9/2025EYENational VisionThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$13.00 ➝ $17.005/9/2025EYENational VisionCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$13.00 ➝ $21.005/9/2025NVAXNovavaxJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetUnderweight ➝ Underweight$9.00 ➝ $7.005/9/2025WRBYWarby ParkerThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$18.00 ➝ $20.005/9/2025WRBYWarby ParkerTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$30.00 ➝ $22.005/8/2025EYENational VisionUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$18.00 ➝ $20.005/8/2025EYENational VisionLoop CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$18.00 ➝ $20.005/8/2025EYENational VisionWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$13.00 ➝ $15.005/7/2025EYENational VisionBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeUnderperform ➝ Buy(Data available from 5/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEYENational Vision$1.85B0.81$2.68 per share7.03$10.60 per share1.78NVAXNovavax$682.16M1.46N/AN/A($6.04) per share-1.02RXSTRxSight$148.31M3.62N/AN/A$4.47 per share2.95WRBYWarby Parker$795.09M2.43N/AN/A$3.08 per share6.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEYENational Vision-$65.90M-$0.33N/A69.853.27-0.81%3.52%1.39%N/ANVAXNovavax-$545.06M$2.65N/A77.382.85-32.18%N/A-17.05%N/ARXSTRxSight-$48.61M-$0.67N/AN/AN/A-23.92%-14.00%-12.51%N/AWRBYWarby Parker-$63.20M-$0.12N/A184.90N/A-4.39%-8.26%-4.37%N/ALatest RXST, WRBY, EYE, and NVAX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025NVAXNovavax$0.71$2.93+$2.22$2.93$204.08 million$666.66 million5/7/2025Q1 2025EYENational Vision$0.32$0.34+$0.02$0.18$510.30 million$510.32 million5/7/2025Q1 2025RXSTRxSight-$0.03-$0.03N/A-$0.20$38.74 million$37.90 million2/27/2025Q4 2024NVAXNovavax-$0.75-$0.51+$0.24-$0.51$85.48 million$88.31 million2/25/2025Q4 2024RXSTRxSight$0.10-$0.15-$0.25-$0.15$40.23 million$40.21 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEYENational VisionN/AN/AN/AN/AN/ANVAXNovavaxN/AN/AN/AN/AN/ARXSTRxSightN/AN/AN/AN/AN/AWRBYWarby ParkerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEYENational Vision0.300.570.37NVAXNovavaxN/A0.930.93RXSTRxSightN/A12.6711.71WRBYWarby ParkerN/A2.472.06Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEYENational VisionN/ANVAXNovavax53.04%RXSTRxSight78.78%WRBYWarby Parker93.24%Insider OwnershipCompanyInsider OwnershipEYENational Vision2.30%NVAXNovavax1.00%RXSTRxSight9.36%WRBYWarby Parker26.55%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEYENational Vision14,00079.05 million76.94 millionOptionableNVAXNovavax1,990160.84 million158.58 millionOptionableRXSTRxSight22040.64 million36.53 millionOptionableWRBYWarby Parker3,030104.50 million74.67 millionOptionableRXST, WRBY, EYE, and NVAX HeadlinesRecent News About These CompaniesAre Options Traders Betting on a Big Move in Warby Parker (WRBY) Stock?May 13 at 8:26 PM | msn.comD. E. Shaw & Co. Inc. Purchases 199,235 Shares of Warby Parker Inc. (NYSE:WRBY)May 13 at 6:02 AM | marketbeat.comWarby Parker (NYSE:WRBY) Shares Gap Up After Analyst UpgradeMay 13 at 1:13 AM | americanbankingnews.comTelsey Advisory Group Cuts Warby Parker (NYSE:WRBY) Price Target to $22.00May 12 at 2:17 AM | americanbankingnews.comHow some early feedback put Warby Parker on the path to successMay 11 at 1:59 PM | msn.comWarby Parker (NYSE:WRBY) Price Target Cut to $22.00 by Analysts at Telsey Advisory GroupMay 11 at 9:08 AM | marketbeat.comDriehaus Capital Management LLC Grows Stake in Warby Parker Inc. (NYSE:WRBY)May 11 at 6:50 AM | marketbeat.comAlgert Global LLC Reduces Stake in Warby Parker Inc. (NYSE:WRBY)May 11 at 4:57 AM | marketbeat.comWarby Parker (NYSE:WRBY) Price Target Raised to $20.00 at The Goldman Sachs GroupMay 11 at 2:23 AM | americanbankingnews.comWarby Parker Inc. (WRBY) Q1 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comEarnings call transcript: Warby Parker Q1 2025 results reveal revenue growthMay 10, 2025 | uk.investing.comWarby Parker Inc. (WRBY): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside PotentialMay 10, 2025 | finance.yahoo.comWarby Parker Inc (WRBY) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...May 9, 2025 | finance.yahoo.comDurable Capital Partners LP Has $218.32 Million Holdings in Warby Parker Inc. (NYSE:WRBY)May 9, 2025 | marketbeat.comWarby Parker Inc. (WRBY): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside PotentialMay 9, 2025 | insidermonkey.comCommit To Buy Warby Parker At $10, Earn 8.8% Annualized Using OptionsMay 8, 2025 | nasdaq.comWarby Parker (NYSE:WRBY) Reports Sales Below Analyst Estimates In Q1 EarningsMay 8, 2025 | finance.yahoo.comHow Warby Parker CEO started billion-dollar eyewear brand at homeMay 8, 2025 | youtube.comWarby Parker (WRBY) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesMay 8, 2025 | zacks.comWarby Parker Inc. (WRBY) Matches Q1 Earnings EstimatesMay 8, 2025 | zacks.comBosun Asset Management LLC Has $2.23 Million Holdings in Warby Parker Inc. (NYSE:WRBY)May 8, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesArcher Aviation Gets Analyst Target Upgrade: Time to Load Up?By Jeffrey Neal Johnson | April 25, 2025View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?Joby Aviation Shares Eye Breakout After Transition Flight WinBy Jeffrey Neal Johnson | April 30, 2025View Joby Aviation Shares Eye Breakout After Transition Flight WinTesla Stock Eyes Breakout With Earnings on DeckBy Sam Quirke | April 16, 2025View Tesla Stock Eyes Breakout With Earnings on DeckAlphabet Slumps as Apple Eyes AI Search—Is the Sell-Off Overdone?By Ryan Hasson | May 8, 2025View Alphabet Slumps as Apple Eyes AI Search—Is the Sell-Off Overdone?Archer Stock Eyes Q1 Earnings After UAE UpdatesBy Jeffrey Neal Johnson | May 7, 2025View Archer Stock Eyes Q1 Earnings After UAE UpdatesRXST, WRBY, EYE, and NVAX Company DescriptionsNational Vision NASDAQ:EYE$18.86 +0.10 (+0.53%) As of 05/13/2025 04:00 PM EasternNational Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.Novavax NASDAQ:NVAX$6.19 -0.15 (-2.37%) As of 05/13/2025 04:00 PM EasternNovavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.RxSight NASDAQ:RXST$13.20 -0.55 (-4.00%) As of 05/13/2025 04:00 PM EasternRxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.Warby Parker NYSE:WRBY$18.49 -0.39 (-2.07%) As of 05/13/2025 03:59 PM EasternWarby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA Stock Surges on Bullish News: How High Could It Climb? NuScale Power in Rebound Mode With Short-Squeeze a Possibility Why Amazon May Never Dip Below $200 Again eBay Nears Big Breakout: Time to Buy the Under-the-Radar Winner? Qualcomm Is 5x Cheaper Than AMD, But Won’t Be for Long Why Boeing May Be Ready to Take Off After Latest Developments Goldman Sachs Warns of 20% Market Sell-Off: Are They Right? 3 Huge S&P 500 Winners From Trump Trade Deal & The Biggest Loser Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
